Cannabidiol
Cannabidiol is a pharmaceutical drug with 114 clinical trials. Currently 20 active trials ongoing. Historical success rate of 87.3%.
Success Metrics
Based on 55 completed trials
Phase Distribution
Phase Distribution
40
Early Stage
49
Mid Stage
11
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
76.4%
55 of 72 finished
23.6%
17 ended early
20
trials recruiting
114
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Mechanisms of Cannabidiol and Sleep in the Context of Alcohol Use
nVNS, CBD, and SoC for Persistent Post-Traumatic Headache
MIVetsCan: Cannabidiol (CBD)-Care Trial
Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
Cannabidiol for Bilateral Total Knee Arthroplasty
Clinical Trials (114)
Mechanisms of Cannabidiol and Sleep in the Context of Alcohol Use
nVNS, CBD, and SoC for Persistent Post-Traumatic Headache
MIVetsCan: Cannabidiol (CBD)-Care Trial
Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
Cannabidiol for Bilateral Total Knee Arthroplasty
Cannabidiol and Prolonged Exposure
Efficacy of Cannabidiol in the Management of Self-injuries in Children and Adolescents With Severe Neurodevelopmental Disorders.
Cannabidiol for Pain Relief of Patients With End-stage mCRPC
Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder
PAIN: A Project Assessing the Impact of a Novel Cannabinoid Product
Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis
Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis
Evaluation of the Efficacy of CANNABIDIOL on the Pruritus in Children With Hereditary Epidermolysis Bullosa
Cannabidiol as a Treatment for PTSD and PTSD Comorbid With TBI
Epidiolex in Obsessive Compulsive Disorder and Related Disorders
Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers
Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use
Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy
Cannabidiol as a Treatment for Social Anxiety Disorder (R61)
Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled Trial
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 114